ADB-BUTINACA acts as an agonist at CB1 and CB2 receptors, mimicking the results of pure cannabinoids. It is usually Employed in analysis to review receptor interactions and their impact on the central anxious system.The technological storage or accessibility is strictly essential for the genuine purpose of enabling the usage of a selected support e